Furthermore, after perfecting gene targeting therapy, CDKN2B-AS1 and miR-199a-5p can be used as targets to start targeted therapy, which may achieve better results and safety than current surgery and radiotherapy for tumours and provide more reliable life safety for patients. The gene discussed is CDKN2B; the disease is neoplasm.